AgBioWorld Members Discuss Raw Milk Lawsuit and French GM Corn Debate
Members Discuss California Raw Milk Lawsuit
Abstract: A member posted an article from Cheese Market News titled “Lawsuit filed over new raw milk standards in California,” which discusses a lawsuit filed by Organic Pastures and Claravale Farms, two raw milk bottlers, over a new legislation that could essentially shut them down. The article states, “In October, the state assembly approved AB1735, which established new standards for coliform bacteria in raw milk sold to consumers. Effective Jan. 1, raw milk sold at the retail level may have a count of no more than 10 coliform bacteria per milliliter in the final product, the same as pasteurized milk.” The raw milk producers are asking that this law be declared “unconstitutional.” The member suggested that those in California consider writing opinion pieces for California newspapers in response to this lawsuit.
French Scientists Argue that the Government is “Misrepresenting” Findings in GM Corn Debate
Abstract: Members discussed an article that appeared in the French press on the “doubts” France’s Provisional High Authority had for the safety of Monsanto’s genetically engineered corn Mon 810. The article that started the discussion reported that, “12 of the 15 scientists who compiled the authority's report issued a statement complaining that Le Grand had misrepresented their findings.” Another member pointed out that much of the French press appeared to be behind the 12 scientists, disagreeing that Mon 810 is dangerous. Finally a member translated a statement from the French Association for Scientific Information (AFIS) on their stance concerning the misrepresentation.
Sources:
AFP article
AFIS statement (In French)
AgBioWorld is comprised of ag-biotech experts who take a keen interest in the latest news and events important to ag-biotech. This blog aims to be a reflection of those events and news stories that have captured our attention. Please share your comments and feelings on the current climate for biotech with us as well.
Best regards,
C.S. Prakash
